爱斯坦-巴尔病毒相关的淋巴瘤:生物学,分子基因组学和精确瘤学
Soumyadeep Datta1, Ajay Gogia2, Saumyaranjan Mallick3
1Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Frontiers in oncology
|December 10, 2025
概括
爱斯坦-巴尔病毒 (EBV) 驱动各种淋巴细胞癌症. 本综述详细介绍了EBV相关的淋巴瘤,其发病,诊断以及新兴的治疗方法,如免疫疗法和疫苗,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 爱斯坦-巴尔病毒 (EBV) 是一种人类的马疹病毒,与许多淋巴细胞恶性瘤有关.
- 了解EBV在癌症发病过程中的作用对于开发有效的治疗方法至关重要.
研究的目的:
- 为提供EBV相关淋巴瘤的全面审查.
- 涵盖EBV驱动淋巴瘤的流行病学,发病,临床表现,病理学,诊断和治疗.
主要方法:
- 关于EBV相关淋巴瘤的文献综述,包括cHL,BL,DLBCL,PTLD和ENKTL.
- 对病毒潜伏蛋白,宿主免疫相互作用和分子特征的分析.
- 评估当前和新兴的治疗策略.
主要成果:
- 详细概述EBV相关淋巴瘤亚型,它们的病理学和诊断.
- 对目前的治疗方法进行批判性评估,并探索新型免疫疗法 (例如检查点抑制剂,CAR-T细胞) 和向疗法.
- 识别挑战,知识差距和未来的研究方向,包括疫苗.
结论:
- 与EBV相关的淋巴瘤多种多样,具有攻击性,需要特定亚型的治疗.
- 免疫疗法和向疗法的进步为改善患者结果提供了新的希望.
- 未来的研究应该专注于预防,增强诊断和新的治疗策略.
相关概念视频
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Mechanisms of Retrovirus-induced Cancers
6.8K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K


